Supprelin La (histrelin acetate)
LHrH(GNrH) Agonist Analog Pituitary Suppressants Implantation Kit
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: Histrelin is used to treat advanced prostate cancer. It is not a cure. Most types of prostate cancer need the hormone testosterone to grow and spread.
Histrelin works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment.
Histrelin is also used by children to treat early puberty (central precocious puberty). It helps to slow abnormally fast bone development so that height and growth rate are near normal and to stop or reverse signs of early puberty (such as breast/pubic hair growth in girls, pubic hair growth in boys). Histrelin works by reducing the amount of testosterone and estrogen.
This medication is used until the doctor decides it is time for puberty to resume.
Generic name: histrelin acetate
Pronunciation: (HISS-treh-lin)
Drug class: LHrH(GNrH) Agonist Analog Pituitary Suppressants
Therapeutic class: Endocrine
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Supprelin La
Indications
The following indications are listed for Supprelin La:
- Advanced Prostatic Carcinoma
Also known as: Advanced Cancer Of Prostate Gland, Advanced Malignant Neoplasm Of Prostate, Advanced Prostate Cancer, Advanced Prostate Malignancy, Advanced Prostatic Cancer.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Pregnancy
There are no severe contraindications for this drug.
- Lower seizure threshold
- Seizure disorder
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Behavioral disorders
- Depression
- Hypersensitivity drug reaction
Rare or Very Rare
- Acute generalized exanthematous pustulosis
- Breakage of implant
- DRESS syndrome
- Idiopathic intracranial hypertension
- Seizure disorder
- Stevens-johnson syndrome
- Suicidal ideation
- Toxic epidermal necrolysis
More Frequent
- Headache disorder
- Injection site sequelae
- Localized edema
Less Frequent
- Epistaxis
- Keratoderma
- Mastalgia
- Pruritus of skin
- Scar of skin
Rare or Very Rare
- Abnormal vaginal bleeding
- Aggressive behavior
- Dysmenorrhea
- Erythema
- Gynecomastia
- Irritability
- Mood changes
- Sensation of cold
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Precocious puberty | ||
| E30.1 | ICD10CM | Precocious puberty |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.